Literature DB >> 22310739

Targeted therapies: Smart tumor, smarter treatment.

M Teresa Villanueva.   

Abstract

Entities:  

Year:  2012        PMID： 22310739     DOI： 10.1038/nrclinonc.2012.4

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.

Authors:  Anirudh Prahallad; Chong Sun; Sidong Huang; Federica Di Nicolantonio; Ramon Salazar; Davide Zecchin; Roderick L Beijersbergen; Alberto Bardelli; René Bernards
Journal:  Nature       Date:  2012-01-26       Impact factor: 49.962
  1 in total
  3 in total

Review 1.  Intratumoral heterogeneity as a therapy resistance mechanism: role of melanoma subpopulations.

Authors:  Rajasekharan Somasundaram; Jessie Villanueva; Meenhard Herlyn
Journal:  Adv Pharmacol       Date:  2012

2.  Should positron emission tomography/computed tomography be the first rather than the last test performed in the assessment of cancer?

Authors:  Rodney J Hicks
Journal:  Cancer Imaging       Date:  2012-09-28       Impact factor: 3.909

3.  Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectives.

Authors:  Chiara F Magnani; Sarah Tettamanti; Francesca Maltese; Nice Turazzi; Andrea Biondi; Ettore Biagi
Journal:  Front Oncol       Date:  2013-04-30       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.